GSK Summary

  1. NYSE
  2. >
  3. GSK
TickerGSK
DescriptionGLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25
GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees99,437
Next Earnings DateOctober 28th, 2020
IV29.088505%
IV Percentile82nd
IV Rank22.75%
IV Skew2.765724
IV Skew Percentile34th
IV Skew SentimentNeutral
Option Volume4,612
Volume5,153,770
Price$35.29
Previous Close$35.09
52-Week High$48.25
52-Week Low$31.43
50-Day Moving Avg.$38.48
200-Day Moving Avg.$40.76
10-Day Avg. Volume4,968,975
20-Day Avg. Volume4,166,350
30-Day Avg. Volume3,722,876
3-Month Avg. Volume3,291,190
PE20.31609
EPS$0.926
Outstanding Shares2,488,840,000
Float2,488,800,179
Market Capitalization$88,682,107,300
CurrencyUSD
UpdatedOctober 23rd, 2020